488 related articles for article (PubMed ID: 34199020)
1. Epigenetic Deregulation of Apoptosis in Cancers.
Ozyerli-Goknar E; Bagci-Onder T
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34199020
[TBL] [Abstract][Full Text] [Related]
2. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
Maleszewska M; Kaminska B
Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
[TBL] [Abstract][Full Text] [Related]
4. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
Gerhauser C
Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs.
Farooqi AA; Fayyaz S; Poltronieri P; Calin G; Mallardo M
Semin Cancer Biol; 2022 Aug; 83():197-207. PubMed ID: 32738290
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase (HDAC) inhibitors and regulation of TRAIL-induced apoptosis.
Fulda S
Exp Cell Res; 2012 Jul; 318(11):1208-12. PubMed ID: 22366288
[TBL] [Abstract][Full Text] [Related]
7. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
8. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
9. Histone Modifying Enzymes in Gynaecological Cancers.
Ramarao-Milne P; Kondrashova O; Barry S; Hooper JD; Lee JS; Waddell N
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669182
[TBL] [Abstract][Full Text] [Related]
10. Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications.
Hori Y; Kikuchi K
Acc Chem Res; 2019 Oct; 52(10):2849-2857. PubMed ID: 31577127
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
Schneider-Stock R; Ocker M
IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
[TBL] [Abstract][Full Text] [Related]
12. Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing.
Majchrzak-Celińska A; Warych A; Szoszkiewicz M
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572577
[TBL] [Abstract][Full Text] [Related]
13. Pharmaco-epigenomics: On the Road of Translation Medicine.
López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of epigenetic mechanisms in cancer.
Maleszewska M; Wojtas B; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
[TBL] [Abstract][Full Text] [Related]
15. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.
Bouyahya A; Mechchate H; Oumeslakht L; Zeouk I; Aboulaghras S; Balahbib A; Zengin G; Kamal MA; Gallo M; Montesano D; El Omari N
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327559
[TBL] [Abstract][Full Text] [Related]
16. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.
Xu S; Ren J; Chen HB; Wang Y; Liu Q; Zhang R; Jiang SW; Li J
Curr Pharm Des; 2014; 20(11):1881-7. PubMed ID: 23888960
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets.
Miranda-Gonçalves V; Lameirinhas A; Henrique R; Jerónimo C
Front Genet; 2018; 9():427. PubMed ID: 30356832
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming and epigenetic modifications on the path to cancer.
Sun L; Zhang H; Gao P
Protein Cell; 2022 Dec; 13(12):877-919. PubMed ID: 34050894
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes in pediatric solid tumors: promising new targets.
Lawlor ER; Thiele CJ
Clin Cancer Res; 2012 May; 18(10):2768-79. PubMed ID: 22589485
[TBL] [Abstract][Full Text] [Related]
20. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
